ASX:MYX

Mayne Pharma Group Limited · ASX · Healthcare · AUD · FY for 2026

Figures on this page computed 2026-11-08 12:41 UTC

Last close

n/aAUD

Market data

9.9xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
AUD
- computed
- Computed from the filing for 2026
-8.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
6.4%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
3.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
0.11Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
AUD
- computed

Safety is the furthest below its sector's middle: 0.45 against 0.58 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

0.96x

-0.17x

-0.66x

0.18x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2026

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2026

Sales0.96x
Its own average over 10 years, 400.7M.
Profit-0.17x
Its own average over 10 years, -146.4M.
Free cash flow-0.66x
Its own average over 10 years, -19.2M.
Debt0.18x
Its own average over 10 years, 241.3M.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at -0.66 times.

Sales is 0.96 times its own 10-year average; Profit is -0.17 times its own 10-year average; Free cash flow is -0.66 times its own 10-year average; Debt is 0.18 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

Sales against its own 10-year average0.96
Source
computed
Statement
income
Fiscal year
2026
Reported in
AUD
Profit against its own 10-year average-0.17
Source
computed
Statement
income
Fiscal year
2026
Reported in
AUD
Free cash flow against its own 10-year average-0.66
Source
computed
Statement
income
Fiscal year
2026
Reported in
AUD
Debt against its own 10-year average0.18
Source
computed
Statement
income
Fiscal year
2026
Reported in
AUD
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
AUD